Apyx Medical Corporation
APYX
$0.8905
-$0.0191-2.10%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -25.38% | -87.67% | -74.14% | -10.06% | 19.28% |
| Total Depreciation and Amortization | -13.44% | -17.92% | -15.67% | -25.58% | -22.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -16.14% | 129.16% | 136.68% | 11.87% | -0.03% |
| Change in Net Operating Assets | -122.46% | -51.17% | 278.28% | 215.67% | 206.25% |
| Cash from Operations | -243.82% | -128.92% | 44.74% | 44.97% | 74.12% |
| Capital Expenditure | -35.46% | 2.06% | 0.84% | 45.54% | 47.23% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -110.72% | -108.53% | -108.86% | 909.63% | 766.73% |
| Total Debt Issued | -- | 268.02% | 268.02% | 268.02% | -- |
| Total Debt Repaid | 99.82% | -26,209.52% | -18,642.37% | -10,640.78% | -7,377.70% |
| Issuance of Common Stock | 8,039.53% | -100.00% | -85.92% | -59.62% | -76.44% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 28.13% | 167.97% | 172.00% | 172.00% | -- |
| Cash from Financing | -79.03% | 186.68% | 190.01% | 192.18% | 14,723.04% |
| Foreign Exchange rate Adjustments | 159.16% | 55.04% | -123.66% | -144.53% | -148.35% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -135.60% | -19.48% | 996.40% | 310.71% | 261.81% |